In this application is disclosed an excellent composition for preventing and/or treating the expression of clinical symptoms in a disease caused by mitochondrial dysfunction, characterized in that said composition is an orally administrable composition containing L-arginine as an active ingredient.

 
Web www.patentalert.com

< Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor

< 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents

> 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

> Lactacystin analogs
~ 00245